<DOC>
	<DOCNO>NCT00660335</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness RG1068 ( synthetic human secretin ) MRCP subject abnormality pancreas .</brief_summary>
	<brief_title>Safety Efficacy Synthetic Human Secretin-Enhanced MRCP Subjects With Abnormalities Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Secretin</mesh_term>
	<criteria>History pancreatitis Medically stable Able give inform consent Prior history pancreatic resection Prior history pancreatic duct drainage procedure Presence pancreatic stent Unstable cardiovascular disease Any contraindication MRI procedure Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>secretin , RG1068 , MRCP , pancreas</keyword>
</DOC>